2026 Global: Companion Animal Clinical Chemistry Analysis Market -Competitive Review (2032) report
Description
The 2026 Global: Companion Animal Clinical Chemistry Analysis Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for companion animal clinical chemistry analysis market by geography and historical trend. The scope of the report extends to sizing of the companion animal clinical chemistry analysis market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The Companion Animal Clinical Chemistry Analysis Market features leading companies like IDEXX Laboratories, Zoetis, Antech Diagnostics (Mars), Heska, and Siemens Healthineers as dominant players, driving innovation in point-of-care testing and diagnostic services. These firms hold significant market shares through advanced analyzers for renal function, electrolytes, and metabolic panels, catering to the rising pet humanization trend that boosts demand for rapid, accurate clinical chemistry assessments in companion animals like dogs and cats. IDEXX Laboratories excels with comprehensive diagnostic platforms integrating clinical chemistry, hematology, and immunology, capturing over 23% market share in related segments via high-throughput systems optimized for serum and plasma samples. Zoetis strengthens its position with POC clinical chemistry solutions under its services arm, emphasizing preventive care and early detection of organ dysfunction in pets. Antech Diagnostics, backed by Mars, leverages AI-driven platforms for efficient veterinary lab testing, while Heska focuses on portable analyzers for in-clinic use, enhancing accessibility for small practices.
Expanding the list, Beckman Coulter, Randox Laboratories, and Skyla Corporation contribute specialized reagents and automated systems tailored for veterinary chemistry, supporting real-time monitoring during critical care and surgeries. Beckman Coulter's high-precision analyzers handle multi-parameter testing from blood samples, ideal for aging pets' lifestyle-related conditions, while Randox offers cost-effective panels for electrolytes and enzymes. SYNLAB and Nationwide Laboratories, prominent in diagnostic services, provide centralized clinical chemistry processing with rapid turnaround, holding key positions in Europe and the U.S. through extensive lab networks. Embark Veterinary and IVC Evidensia integrate chemistry analysis into broader companion animal diagnostics, focusing on molecular and imaging synergies for comprehensive pet health profiles. These mid-tier players emphasize scalability, with SYNLAB's growth in cytopathology-adjacent services projected at over 9% CAGR, complementing chemistry dominance.
Market leaders like CVS Group, Greencross Vets, and The Animal Medical Center round out the top ten, combining clinical chemistry with vet clinic operations for end-to-end pet care. CVS Group advances POC chemistry in the UK, integrating it with hematology for holistic diagnostics, while Greencross expands in Australia via strategic acquisitions. The Animal Medical Center pioneers specialized testing for high-value companion animals, aligning with trends in precision medicine. Collectively, these companies fuel market growth through innovations like AI-enhanced analyzers and sustainable practices, with the segment projected to expand amid rising pet ownership and veterinary investments, ensuring robust competition and technological advancement. (448 words)
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for companion animal clinical chemistry analysis market by geography and historical trend. The scope of the report extends to sizing of the companion animal clinical chemistry analysis market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The Companion Animal Clinical Chemistry Analysis Market features leading companies like IDEXX Laboratories, Zoetis, Antech Diagnostics (Mars), Heska, and Siemens Healthineers as dominant players, driving innovation in point-of-care testing and diagnostic services. These firms hold significant market shares through advanced analyzers for renal function, electrolytes, and metabolic panels, catering to the rising pet humanization trend that boosts demand for rapid, accurate clinical chemistry assessments in companion animals like dogs and cats. IDEXX Laboratories excels with comprehensive diagnostic platforms integrating clinical chemistry, hematology, and immunology, capturing over 23% market share in related segments via high-throughput systems optimized for serum and plasma samples. Zoetis strengthens its position with POC clinical chemistry solutions under its services arm, emphasizing preventive care and early detection of organ dysfunction in pets. Antech Diagnostics, backed by Mars, leverages AI-driven platforms for efficient veterinary lab testing, while Heska focuses on portable analyzers for in-clinic use, enhancing accessibility for small practices.
Expanding the list, Beckman Coulter, Randox Laboratories, and Skyla Corporation contribute specialized reagents and automated systems tailored for veterinary chemistry, supporting real-time monitoring during critical care and surgeries. Beckman Coulter's high-precision analyzers handle multi-parameter testing from blood samples, ideal for aging pets' lifestyle-related conditions, while Randox offers cost-effective panels for electrolytes and enzymes. SYNLAB and Nationwide Laboratories, prominent in diagnostic services, provide centralized clinical chemistry processing with rapid turnaround, holding key positions in Europe and the U.S. through extensive lab networks. Embark Veterinary and IVC Evidensia integrate chemistry analysis into broader companion animal diagnostics, focusing on molecular and imaging synergies for comprehensive pet health profiles. These mid-tier players emphasize scalability, with SYNLAB's growth in cytopathology-adjacent services projected at over 9% CAGR, complementing chemistry dominance.
Market leaders like CVS Group, Greencross Vets, and The Animal Medical Center round out the top ten, combining clinical chemistry with vet clinic operations for end-to-end pet care. CVS Group advances POC chemistry in the UK, integrating it with hematology for holistic diagnostics, while Greencross expands in Australia via strategic acquisitions. The Animal Medical Center pioneers specialized testing for high-value companion animals, aligning with trends in precision medicine. Collectively, these companies fuel market growth through innovations like AI-enhanced analyzers and sustainable practices, with the segment projected to expand amid rising pet ownership and veterinary investments, ensuring robust competition and technological advancement. (448 words)
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.